The consignment of two of the five essential drugs administered daily to tuberculosis patients for a period of 18 to 24 months had until yesterday not arrived in Dar es Salaam, it has been learnt.
The Ministry of Health and Social Welfare admitted on November 14 this year that the two essential drugs were out of stock, saying a consignment had been shipped out and was expected to be delivered in the country by last week.
The admission followed revelation by The Guardian that the national Tuberculosis Hospital, Kibong’oto in Kilimanjaro Region was short of the two drugs to treat multidrug resistant tuberculosis.
But yesterday Dr Saidi Egwaga, Programme Manager, National TB and Leprosy told this paper that they were waiting for the consignment to arrive anytime from yesterday.
“We expect to receive the drugs anytime from today (Monday),” he said, stressing however that the patients were not at risk.
He said they might be at risk if they stay 30 days without the medication.
Currently, there are 27 MDR-TB patients at Kibong’oto hospital undergoing the first phase of treatment which takes 6 – 8 months.
Last week the ministry through its statement which was signed by the Permanent Secretary, Blandina Nyoni said the consignment was expected to arrive by air last week and would be sent immediately to Kibong’oto hospital.
The ministry said that Tanzania’s share of the drugs had initially been expected to arrive in the country by October this year. “This delay is beyond the country’s control due to the fact that there are only 2 companies worldwide that manufacture the drugs. This is coupled by the high demand from various countries in the world including Tanzania,” said a statement.
One of the female patients admitted to the hospital for several months now but who sought strict anonymity “for my safety” told this paper that they were worried about their situation, saying they had yet to receive the drugs as promised by the government last week.
The treatment of MDR-TB patients was suspended on November 8 this year when the stock of two of the five essential drugs was exhausted.
“This was caused by delay in receiving the consignment of MDR-TB drugs from manufacturers, initially expected last month,” said a Ministry statement, which explained that MDR-TB is treated with a combination of five essential drugs which are administered daily to patients for a period of 18 -24 months.
However according to the ministry the decision to stop treatment was reached following consultation between a panel of doctors providing MDR-TB service at Kibong’oto hospital, supervisors from the Ministry and experts from the University of San Francisco, California, United States of America.
“They unanimously agreed that the remaining 3 drugs could not make an effective regimen to treat MDR-TB patients and that continuing treatment could lead to creation of resistance to the remaining drugs,” said part of the statement.
According to the statement the panel had agreed that stopping the said treatment regimen did not pose additional danger to the patients since most of them had already converted to non-infectious status.
However the source said the management had placed them under great risk because they are always told that if they skip a dose even for one day they risk their lives.
An earlier group of 39 patients had already completed this phase and was discharged to continue with treatment under supervision of the district hospital or nearest health centre.
SOURCE: The Guardian Newspaper (22 Nov 2011)